Sandu Pharmaceuticals Ltd Q1 FY2024-2025 Results: Summary

Revenue
₹17.09Cr
Net Profits
₹0.17Cr
Net Profit Margins
0.99%

Highlights

Revenue:

Sandu Pharmaceuticals Ltd’s revenue fell -3.23% since last year same period to ₹17.09Cr in the Q1 2024-2025. On a quarterly growth basis, Sandu Pharmaceuticals Ltd has generated 7.42% jump in its revenue since last 3-months.

Net Profits:

Sandu Pharmaceuticals Ltd’s net profit jumped 54.55% since last year same period to ₹0.17Cr in the Q1 2024-2025. On a quarterly growth basis, Sandu Pharmaceuticals Ltd has generated -71.19% fall in its net profits since last 3-months.

Net Profit Margins:

Sandu Pharmaceuticals Ltd’s net profit margin jumped 59.7% since last year same period to 0.99% in the Q1 2024-2025. On a quarterly growth basis, Sandu Pharmaceuticals Ltd has generated -73.18% fall in its net profit margins since last 3-months.

FAQs

The revenue for Sandu Pharmaceuticals Ltd in the Q1 results 2024 was ₹17.09Cr.

The net profit for Sandu Pharmaceuticals Ltd in the Q1 results 2024 was ₹0.17Cr.

The net profit margin for Sandu Pharmaceuticals Ltd in the Q1 results 2024 was 0.99%.

The revenue for Sandu Pharmaceuticals Ltd in the Q1 results 2023 was ₹17.66Cr.

The net profit for Sandu Pharmaceuticals Ltd in the Q1 results 2023 was ₹0.11Cr.

The net profit margin for Sandu Pharmaceuticals Ltd in the Q1 results 2023 was 0.62%.